◆ TICKERBASEVista interattiva →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › Tutte le azioni › 4527 · English version

Rohto Pharmaceutical Co.,Ltd. (4527)

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Consumer Defensive · Wall Street (USA) · Ultimo aggiornamento: 2026-10-02

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.

Dati chiave

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico2026-03-312025-03-312024-03-312023-03-312022-03-31
Entrate totaliJPY 343.7BJPY 308.6BJPY 270.8BJPY 238.7B—
Utile lordoJPY 192.7BJPY 174.4BJPY 157.3BJPY 137.4B—
Risultato Operativo (EBIT)JPY 41.1BJPY 38.2BJPY 40.1BJPY 34.0B—
Reddito nettoJPY 34.2BJPY 30.8BJPY 30.9BJPY 26.4B—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 4527. /companies/us/4527

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.